You searched notice-intent-publish-funding-opportunity-announcement-understanding-neurological-effects-0

To submit a grant posting, please fill out our web form or download the form so that you can email us at List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at

Treat FTD Fund

Sponsor: The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD)

Award: Up to $2,500,000 over 1 – 3 years, based on stage and scope of the trial.

Due Date: Letter of Intent due September 30th, 2024. Full Proposal due December 9th, 2024.

Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in MCI and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required) (RFA-NS-25-010)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: Direct Costs cannot exceed $6,700,000 per year. The maximum project period is 7 years. NIH intends to fund one award contingent upon NIH appropriations.

Due Date: LOI due December 24, 2024. Application due January 24, 2025.

Current Filters

  • Keyword: notice-intent-publish-funding-opportunity-announcement-understanding-neurological-effects-0 x

Remove all filters

Filter By